Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm "ASCOT - LLA"

Completed

Phase N/A Results

Summary of Purpose

To compare the long-term benefits of lowering cholesterol in hypertensive patients for the prevention of coronary heart disease and stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 April 2003.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Pfizer

Trial Design

Multicenter, double-blind randomized subset of the ASCOT trial.

Contacts

  • Department of Clinical Pharmacology Imperial College London, St, Mary's Campus London W2 1PG, UK

    n.poulter@imperial.ac.uk